Grant: Cat Gr: STBBI Research in Canada: Beyond HIV/AIDS and Hepatitis C- Syphilis
University of Victoria (British Columbia)
$100,000.00
Lipidomic profiling of human and rabbit serum for development of novel tools to combat syphilis
EF 2024-25
Résumé
Syphilis is a sexually transmitted infection causing severe, life-lasting health problems when untreated. It increases the risk of acquisition and transmission of HIV and harms unborn children when transmitted via the placenta during pregnancy. Worldwide, the incidence of syphilis has been rapidly rising. At the same time, global shortage of appropriate antibiotics has been hindering treatment of the existing syphilis cases.
The proposed project will focus on the following challenges. (1) The current diagnostic tests that detect an active infection have low sensitivity in the early stages of syphilis (62-76%), delaying treatment and increasing chances of further transmission. (2) Vaccine and drug trials are slow due to the lack of suitable molecular tests indicative of an active infection in rabbits. To address these issues, we will develop novel, lipid-based tools for combating syphilis.
Our preliminary data show that infection with the causative agent of syphilis, Treponema pallidum, leads to alteration of lipid homeostasis in the host. We, therefore, hypothesize that lipids are suitable biomarkers of syphilis. In this project, we aim to use mass spectrometry and molecular biology approaches to (1) Develop and validate a novel lipid-based diagnostic assay, LIST (LIpid Syphilis Test), using hundreds of defined serum samples from people with and without syphilis, (2) Improve the sensitivity and specificity of the existing diagnostic tests detecting anti-cardiolipin antibodies, and (3) Design a lipid-based tool for monitoring the course of infection in rabbits. Our team combines expertise in T. pallidum biology, mass spectrometry, rabbit model of syphilis, and clinical diagnostics, ensuring the feasibility of the proposed work.
Novel lipid-based assays described in this proposal will aid in fast and efficient diagnostic methods and vaccine testing pipelines. These tools are essential for decreasing, and eventually eliminating, syphilis cases around the world.
Programme
Cat Gr: STBBI Research in Canada: Beyond HIV/AIDS and Hepatitis C- Syphilis
Bénéficiaire
Emplacement
British Columbia, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
507597
Name
Goodlett David R
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
STBBI Research in Canada: Beyond HIV/AIDS and Hepatitis C (Catalyst)
Projecttitle
Lipidomic profiling of human and rabbit serum for development of novel tools to combat syphilis
Programtype2
Operating Grants
Orgnameinp2
University of Victoria (British Columbia)
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Cat Gr: STBBI Research in Canada: Beyond HIV/AIDS and Hepatitis C- Syphilis
Keyworddelim
Cardiolipin; Diagnostics; Infection Markers; Lipid Remodelling; Lipidomics; Lipids; Mass Spectrometry; Syphilis; Treponema Pallidum; Vaccine Testing
Abstract
Syphilis is a sexually transmitted infection causing severe, life-lasting health problems when untreated. It increases the risk of acquisition and transmission of HIV and harms unborn children when transmitted via the placenta during pregnancy. Worldwide, the incidence of syphilis has been rapidly rising. At the same time, global shortage of appropriate antibiotics has been hindering treatment of the existing syphilis cases.
The proposed project will focus on the following challenges. (1) The current diagnostic tests that detect an active infection have low sensitivity in the early stages of syphilis (62-76%), delaying treatment and increasing chances of further transmission. (2) Vaccine and drug trials are slow due to the lack of suitable molecular tests indicative of an active infection in rabbits. To address these issues, we will develop novel, lipid-based tools for combating syphilis.
Our preliminary data show that infection with the causative agent of syphilis, Treponema pallidum, leads to alteration of lipid homeostasis in the host. We, therefore, hypothesize that lipids are suitable biomarkers of syphilis. In this project, we aim to use mass spectrometry and molecular biology approaches to (1) Develop and validate a novel lipid-based diagnostic assay, LIST (LIpid Syphilis Test), using hundreds of defined serum samples from people with and without syphilis, (2) Improve the sensitivity and specificity of the existing diagnostic tests detecting anti-cardiolipin antibodies, and (3) Design a lipid-based tool for monitoring the course of infection in rabbits. Our team combines expertise in T. pallidum biology, mass spectrometry, rabbit model of syphilis, and clinical diagnostics, ensuring the feasibility of the proposed work.
Novel lipid-based assays described in this proposal will aid in fast and efficient diagnostic methods and vaccine testing pipelines. These tools are essential for decreasing, and eventually eliminating, syphilis cases around the world.
Competitiondate
202405
Approvedterm2
1 yr 0 mth
Pinamesdelim
Goodlett, David R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~